Common Skin, STBBI, and Urinary Infections: Antimicrobial Treatment Guide
Skin and Soft Tissue Infections
Uncomplicated Cellulitis (Non-purulent)
Beta-lactam monotherapy is the standard of care, successful in 96% of patients, as MRSA is uncommon in typical cellulitis even in high-prevalence settings 1.
Oral regimens (first-line):
- Cephalexin 500 mg every 6 hours for 5 days 1
- Dicloxacillin 250-500 mg every 6 hours for 5 days 1
- Amoxicillin 500 mg three times daily for 5 days 1
- Penicillin V 250-500 mg four times daily for 5 days 1
IV regimens (hospitalized patients):
Treatment duration: Exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved 1.
Purulent Cellulitis or MRSA Risk Factors
Add MRSA coverage when specific risk factors are present: penetrating trauma, injection drug use, purulent drainage/exudate, known MRSA colonization, or systemic inflammatory response syndrome 1.
Oral regimens:
- Clindamycin 300-450 mg every 6 hours for 5 days (if local MRSA resistance <10%) 2, 1
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin or amoxicillin) for 5 days 2, 1
- Doxycycline 100 mg twice daily PLUS a beta-lactam for 5 days 2, 1, 3
IV regimens:
- Vancomycin 15-20 mg/kg IV every 8-12 hours (A-I evidence) 2, 1
- Linezolid 600 mg IV twice daily (A-I evidence) 2, 1
- Daptomycin 4 mg/kg IV once daily (A-I evidence) 2, 1
Critical caveat: Never use doxycycline or TMP-SMX as monotherapy for cellulitis—streptococcal coverage is inadequate 1.
Severe Cellulitis with Systemic Toxicity or Suspected Necrotizing Fasciitis
Mandatory broad-spectrum combination therapy is required for patients with fever, hypotension, tachycardia, altered mental status, or suspected necrotizing infection 1.
Recommended regimens:
- Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
- Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 1
- Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1
Duration: 7-14 days based on clinical response 1.
Skin Abscesses
Incision and drainage is the primary treatment; antibiotics play only a subsidiary role 1.
Antibiotics indicated only if:
- Surrounding cellulitis present 2
- Systemic signs of infection 2
- Immunocompromised host 2
- Multiple lesions 2
If antibiotics needed, use MRSA-active agents as above 2.
Bite Wounds (Animal and Human)
Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days provides single-agent coverage for polymicrobial oral flora 2, 1.
Alternative for penicillin allergy:
- Doxycycline 100 mg twice daily PLUS metronidazole 500 mg three times daily 2
- Moxifloxacin 400 mg daily (covers both aerobes and anaerobes) 2
Sexually Transmitted and Blood-Borne Infections (STBBI)
Gonorrhea (Urethritis/Cervicitis)
Ceftriaxone 250 mg IM as a single dose is first-line therapy 2.
Alternative (if ceftriaxone unavailable):
- Azithromycin 2 g orally as a single dose 4
Note: Fluoroquinolones are no longer recommended due to widespread resistance 2.
Chlamydia (Urethritis/Cervicitis)
Azithromycin 1 g orally as a single dose 2, 4.
Alternative:
Non-Gonococcal Urethritis (NGU)
Doxycycline 100 mg orally twice daily for 7 days 2, 3.
Alternative:
Syphilis (Early, <1 year duration)
Benzathine penicillin G 2.4 million units IM as a single dose is first-line 2.
For penicillin allergy:
Syphilis (Late, >1 year duration)
Benzathine penicillin G 2.4 million units IM weekly for 3 weeks 2.
For penicillin allergy:
Chancroid (Genital Ulcer Disease)
Azithromycin 1 g orally as a single dose 4.
Alternatives:
Urinary Tract Infections
Uncomplicated Cystitis (Lower UTI)
First-line agents:
- Nitrofurantoin 100 mg twice daily for 5 days 5
- TMP-SMX 1 double-strength tablet twice daily for 3 days 6, 5
Alternatives (if resistance patterns permit):
Avoid fluoroquinolones as first-line due to increasing resistance and adverse effects 7, 5.
Complicated Urinary Tract Infections (cUTI)
Fluoroquinolones should not be used as first-line for serious cUTIs when risk factors for resistant organisms exist 5.
Mild-to-moderate cUTI (oral therapy):
- TMP-SMX 1 double-strength tablet twice daily for 7-14 days 6, 5
- Ciprofloxacin 500 mg twice daily for 7-14 days (if local resistance <10%) 5
- Levofloxacin 750 mg daily for 5-7 days (if local resistance <10%) 5
Severe cUTI or risk factors for resistant organisms (IV therapy):
- Piperacillin-tazobactam 3.375 g IV every 6 hours 5
- Carbapenems (ertapenem 1 g IV daily, meropenem 1 g IV every 8 hours) 5
- Ceftriaxone 1-2 g IV daily (if susceptibility confirmed) 5
Duration: 7-14 days for cUTI; up to 4 weeks for complicated pyelonephritis with abscess 5.
Acute Pyelonephritis (Uncomplicated)
Outpatient oral therapy:
- Ciprofloxacin 500 mg twice daily for 7 days 5
- Levofloxacin 750 mg daily for 5 days 5
- TMP-SMX 1 double-strength tablet twice daily for 14 days (if local resistance <20%) 6, 5
Hospitalized patients:
- Ceftriaxone 1-2 g IV daily 5
- Ciprofloxacin 400 mg IV every 12 hours 5
- Piperacillin-tazobactam 3.375 g IV every 6 hours (if severe or septic) 5
Transition to oral therapy once clinically stable, typically after 24-48 hours 5.
Acute Bacterial Prostatitis
Empiric therapy (pending cultures):
- Ciprofloxacin 500 mg orally twice daily for 4-6 weeks 8
- Levofloxacin 500 mg orally daily for 4-6 weeks 8
- TMP-SMX 1 double-strength tablet twice daily for 4-6 weeks 8, 6
Severe/hospitalized patients:
- Piperacillin-tazobactam 4.5 g IV every 6-8 hours 8
- Ceftriaxone 1-2 g IV daily PLUS gentamicin 5 mg/kg daily 8
Critical caveat: Do NOT perform prostatic massage in acute bacterial prostatitis—risk of bacteremia and sepsis 8.
Key Principles Across All Infections
Antibiotic Stewardship
- Avoid fluoroquinolones as first-line for mild infections where other options exist due to serious adverse effects and resistance 7, 5
- Reserve carbapenems, linezolid, and daptomycin for life-threatening situations or confirmed resistant organisms 9
- Use shortest effective duration: 5 days for uncomplicated cellulitis, 3 days for uncomplicated cystitis 1, 5
Common Pitfalls
- Do not add MRSA coverage reflexively to cellulitis without specific risk factors 1
- Do not use doxycycline or TMP-SMX as monotherapy for cellulitis—inadequate streptococcal coverage 1
- Do not continue ineffective antibiotics beyond 48 hours—reassess for complications or resistant organisms 1
- Do not prescribe antibiotics for simple abscesses without surrounding cellulitis—drainage is primary treatment 2, 1